Orange Book product
ESCITALOPRAM OXALATE EQ 5MG BASE/5ML
Orange Book ANDA 202221 · HETERO LABS LTD UNIT III · Prescription
Key facts
| Proprietary name | ESCITALOPRAM OXALATE |
|---|---|
| Active ingredients | ESCITALOPRAM OXALATE |
| Strength | EQ 5MG BASE/5ML |
| Dosage form | SOLUTION |
| Route | ORAL |
| Application | ANDA202221 |
| Applicant holder | HETERO LABS LTD UNIT III |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AA |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | Yes |
| Approval date | Jun 12, 2012 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.